An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma (Q43723284)

From Wikidata
Jump to navigation Jump to search
scientific article published in June 1998
edit
Language Label Description Also known as
English
An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma
scientific article published in June 1998

    Statements

    An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma (English)
    Michon JM
    Hartmann O
    Bouffet E
    Meresse V
    Rubie H
    Bordigoni P
    Cattiaux E
    Bernard JL
    Lemerle J
    Zucker JM
    Philip T
    1 June 1998
    1063-1069

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit